Identifícate
Grupos
Investigadores/as
Resultados
Financiación
Financiador
:
SANTEN SA
Ámbito
Europeo (1)
1 financiaciones
- 60.677€
datos disponibles desde el año 2019
2019
A PHASE IV OPEN-LABEL CLINICAL TRIAL TO EVALUATE THE EFFICACY OF IKERVIS ON CLINICAL PARAMETERS AND MOLECULAR/CELLULAR BIOMARKERS IN DRY PATIENTS WITH SEVERE DERATITIS WHO HAVE NOT IMPROVED DESPITE REGULAR USE OF TEAR SUBSTITUTES BEFORE AND AFTER EXPOSURE TO AN ADVERSE CONTROLLED ENVIRONMENT.
euro
60.677,20
Contactar
Aviso Legal
translate
es
arrow_drop_down
translate
es
arrow_drop_down
ca
eu
gl
en
fr
de